Diversified Healthcare Trust (DHC) P/E Ratio History
Historical price-to-earnings valuation from 2000 to 2022
Loading P/E history...
Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of March 1, 2026, Diversified Healthcare Trust (DHC) trades at a price-to-earnings ratio of -5.7x, with a stock price of $6.76 and trailing twelve-month earnings per share of $-1.19.
The current P/E is 125% below its 5-year average of 22.7x. Over the past five years, DHC's P/E has ranged from a low of 0.6x to a high of 49.3x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Real Estate sector median P/E of 23.4x, DHC trades at a 124% discount to its sector peers. The sector includes 170 companies with P/E ratios ranging from 1.8x to 176.8x.
Relative to the broader market, DHC trades at a notable discount to the S&P 500 median P/E of 26.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our DHC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
Peer Comparison
P/E metrics vs. Diversified healthcare real estate peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
WELLWelltower Inc. | $144B | 149.0 | -Best | -11% |
VTRVentas, Inc. | $40B | 159.6 | -Best | +184%Best |
DOCHealthpeak Properties, Inc. | $12B | 176.8 | -Best | -72% |
SILASila Realty Trust, Inc. | $1B | 42.9Lowest | -Best | -20% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
Historical P/E Data
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $0.99 | $1.75 | 0.6x | -97% |
| FY2022 Q2 | $1.82 | $1.71 | 1.1x | -95% | |
| FY2022 Q1 | $3.20 | $2.03 | 1.6x | -93% | |
| FY2021 Q4 | Fri Dec 31 2021 00:00:00 GM | $3.09 | $0.74 | 4.2x | -81% |
| FY2019 Q1 | Sun Mar 31 2019 00:00:00 GM | $11.78 | $0.34 | 34.6x | +58% |
| FY2018 Q4 | Mon Dec 31 2018 00:00:00 GM | $11.72 | $1.20 | 9.8x | -56% |
| FY2018 Q3 | Sun Sep 30 2018 00:00:00 GM | $17.56 | $1.97 | 8.9x | -59% |
| FY2018 Q2 | Sat Jun 30 2018 00:00:00 GM | $18.09 | $1.92 | 9.4x | -57% |
| FY2018 Q1 | Sat Mar 31 2018 00:00:00 GM | $15.66 | $1.47 | 10.7x | -51% |
| FY2017 Q4 | Sun Dec 31 2017 00:00:00 GM | $19.15 | $0.62 | 31.0x | +41% |
| FY2017 Q3 | Sat Sep 30 2017 00:00:00 GM | $19.55 | $0.53 | 37.1x | +69% |
| FY2017 Q2 | Fri Jun 30 2017 00:00:00 GM | $20.44 | $0.51 | 40.3x | +83% |
Average P/E for displayed period: 21.9x
See DHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DHC Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare DHC vs WELL
See how DHC stacks up against sector leader Welltower Inc..
Start ComparisonFrequently Asked Questions
Is DHC stock overvalued or undervalued?
DHC trades at -5.7x P/E, below its 5-year average of 22.7x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does DHC's valuation compare to peers?
Diversified Healthcare Trust P/E of -5.7x compares to sector median of 23.4x. The discount suggests lower growth expectations or higher risk.
What is DHC's PEG ratio?
DHC PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2000-2022.